| dc.contributor.author | Shakak, Amany Osman | |
| dc.contributor.author | Supervisor,- Humodi Ahmed Saeed | |
| dc.date.accessioned | 2014-03-11T06:46:27Z | |
| dc.date.available | 2014-03-11T06:46:27Z | |
| dc.date.issued | 2006-02-01 | |
| dc.identifier.citation | Shakak,Amany Osman.IN VITRO ACTIVITY OF AMPICILLIN AGAINST BETA LACTAMASE PRODUCERS/Amany Osman Shakak;Humodi Ahmed Saeed.-Khartoum:Sudan University of Science and Technology,college of Medical Laboratory Science,2006.-68p. : ill. ; 28cm.-M.Sc. | en_US |
| dc.identifier.uri | http://repository.sustech.edu/handle/123456789/3857 | |
| dc.description | Thesis | en_US |
| dc.description.abstract | This study was carried out in Khartoum State, during August to October 2005. The study was designed to evaluate in vitro activity of ampicillin against β-lactamase producers. Two hundred clinical specimens were collected. 38.5% of the specimens were ear swabs, 36.5% wound swabs, and 25% urine. Cultivation of these specimens on enriched and / or differential media yielded isolation of 189 isolates. β-Lactamase producers were detected by β-lactamase acidimetric method. Result showed that positive isolates were S.aureus (31.9%), E.coli (21.6%), Ps. aeruginosa (16.4%), K. pneumoniae (15.5%), P.mirabilis (13.7%) and P. vulgaris (0.9%). Ampicillin activity against β-lactamase determined by using National Committee for Clinical Laboratory Standards (NCCLS) modified Kirby- Bauer Disc Diffusion technique. The result revealed that only 8.6% of the β-lactamase producers were sensitive to ampicillin while 91.4% were resist the action of ampicillin. | en_US |
| dc.description.sponsorship | Sudan University of Science and Technology | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Sudan University of Science and Technology | en_US |
| dc.subject | Drugs-Effective | en_US |
| dc.subject | activity-ampicillin-against β-lactamase | en_US |
| dc.title | IN VITRO ACTIVITY OF AMPICILLIN AGAINST BETA LACTAMASE PRODUCERS | en_US |
| dc.type | Thesis | en_US |